hydroxyurea has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, R | 1 |
| Sullivan, DK | 1 |
| Azizian, NG | 1 |
| Liu, Y | 1 |
| Li, Y | 1 |
| Gregor, JI | 1 |
| Kilian, M | 1 |
| Heukamp, I | 1 |
| Kiewert, C | 1 |
| Kristiansen, G | 1 |
| Schimke, I | 1 |
| Walz, MK | 1 |
| Jacobi, CA | 1 |
| Wenger, FA | 1 |
2 other studies available for hydroxyurea and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Ce | 2021 |
Effects of selective COX-2 and 5-LOX inhibition on prostaglandin and leukotriene synthesis in ductal pancreatic cancer in Syrian hamster.
Topics: Animals; Carcinoma, Pancreatic Ductal; Celecoxib; Cricetinae; Cyclooxygenase Inhibitors; Dinoproston | 2005 |